Downregulation of MCJ improves mitochondrial damage, increases ATP levels, and reduces the GSSG/GSH ratio and mtROS in ccRCC cells, suggesting an enhancement of mitochondrial function. The gene discussed is DNAJC15; the disease is nonpapillary renal cell carcinoma.